公开(公告)号：US10470871B2

公开(公告)日：2019-11-12

申请号：US15686218

申请日：2017-08-25

Applicant: TriVascular, Inc.

Inventor： Michael V. Chobotov ,  Robert G. Whirley

IPC: A61F2/07 ,  A61F2/962 ,  A61F2/89 ,  A61F2/82 ,  A61F2/844 ,  A61F2/915 ,  A61F2/958 ,  A61F2/954 ,  A61F2/06 ,  A61F2/848 ,  A61F2/95 ,  A61M25/01

Abstract: This invention is a system for the treatment of body passageways; in particular, vessels with vascular disease. The system includes an endovascular graft with a low-profile delivery configuration and a deployed configuration in which it conforms to the morphology of the vessel or body passageway to be treated as well as various connector members and stents. The graft is made from an inflatable graft body section and may be bifurcated. One or more inflatable cuffs may be disposed at either end of the graft body section. At least one inflatable channel is disposed between and in fluid communication with the inflatable cuffs.

公开(公告)号：US20190117372A1

公开(公告)日：2019-04-25

申请号：US16231219

申请日：2018-12-21

Applicant: TriVascular, Inc.

Inventor： Michael V. Chobotov ,  Robert G. Whirley ,  Joseph W. Humphrey

IPC: A61F2/07 ,  A61F2/966 ,  A61F2/954

CPC classification number: A61F2/07 ,  A61F2/89 ,  A61F2/954 ,  A61F2/966 ,  A61F2002/067 ,  A61F2002/075 ,  A61F2002/8486 ,  A61F2002/9511 ,  A61F2220/005 ,  A61F2220/0058 ,  A61F2250/0003 ,  A61F2250/0069

Abstract: A hybrid modular endovascular graft wherein a main graft is sized to span at least a portion of a target vessel lesion in a large percentage of patients. Graft extensions may be secured to the main graft to extend the main graft and provide a sealing function for some applications.

公开(公告)号：US09993328B2

公开(公告)日：2018-06-12

申请号：US13803046

申请日：2013-03-14

Applicant: TriVascular, Inc.

Inventor： Sarah Young ,  Cheng Li ,  Michael V. Chobotov ,  Patrick Stephens ,  Robert G. Whirley

IPC: A61F2/07 ,  A61F2/06 ,  A61L31/04 ,  A61L31/14 ,  A61F2/88 ,  A61F2/89 ,  A61F2/82 ,  A61F2/915

CPC classification number: A61F2/06 ,  A61F2/07 ,  A61F2/88 ,  A61F2/89 ,  A61F2002/065 ,  A61F2002/067 ,  A61F2002/072 ,  A61F2002/825 ,  A61F2002/91516 ,  A61F2002/91541 ,  A61F2230/0078 ,  A61F2250/0003 ,  A61L31/048 ,  A61L31/146 ,  Y10T29/49927 ,  C08L27/18

Abstract: Stent-grafts for treating thoracic aortic aneurysms and abdominal aortic aneurysms include graft portions having inflatable channels and graft extensions. The graft extensions include an undulating wire stent and porous, but substantially fluid impermeable, polytetrafluoroethylene (PTFE) graft materials.

公开(公告)号：US20170348087A1

公开(公告)日：2017-12-07

申请号：US15686218

申请日：2017-08-25

Applicant: TriVascular, Inc.

Inventor： Michael V. Chobotov ,  Robert G. Whirley

IPC: A61F2/07 ,  A61F2/89 ,  A61F2/915 ,  A61F2/82 ,  A61F2/962 ,  A61F2/844 ,  A61F2/958 ,  A61M25/01 ,  A61F2/95 ,  A61F2/848 ,  A61F2/06 ,  A61F2/954

CPC classification number: A61F2/07 ,  A61F2/82 ,  A61F2/844 ,  A61F2/89 ,  A61F2/915 ,  A61F2/954 ,  A61F2/958 ,  A61F2/962 ,  A61F2002/065 ,  A61F2002/072 ,  A61F2002/075 ,  A61F2002/825 ,  A61F2002/8486 ,  A61F2002/91508 ,  A61F2002/91516 ,  A61F2002/91558 ,  A61F2002/91583 ,  A61F2002/9505 ,  A61F2002/9511 ,  A61F2002/9517 ,  A61F2220/005 ,  A61F2220/0058 ,  A61F2250/0003 ,  A61F2250/0036 ,  A61M2025/0177

Abstract: This invention is a system for the treatment of body passageways; in particular, vessels with vascular disease. The system includes an endovascular graft with a low-profile delivery configuration and a deployed configuration in which it conforms to the morphology of the vessel or body passageway to be treated as well as various connector members and stents. The graft is made from an inflatable graft body section and may be bifurcated. One or more inflatable cuffs may be disposed at either end of the graft body section. At least one inflatable channel is disposed between and in fluid communication with the inflatable cuffs.

公开(公告)号：US12016766B2

公开(公告)日：2024-06-25

申请号：US16902155

申请日：2020-06-15

Applicant: TriVascular, Inc.

Inventor： Michael V. Chobotov ,  Robert G. Whirley ,  Joseph W. Humphrey

IPC: A61F2/07 ,  A61F2/954 ,  A61F2/966 ,  A61F2/06 ,  A61F2/848 ,  A61F2/89 ,  A61F2/95

CPC classification number: A61F2/07 ,  A61F2/954 ,  A61F2/966 ,  A61F2002/067 ,  A61F2002/075 ,  A61F2002/8486 ,  A61F2/89 ,  A61F2002/9511 ,  A61F2220/005 ,  A61F2220/0058 ,  A61F2250/0003 ,  A61F2250/0069

Abstract: A hybrid modular endovascular graft wherein a main graft is sized to span at least a portion of a target vessel lesion in a large percentage of patients. Graft extensions may be secured to the main graft to extend the main graft and provide a sealing function for some applications.

公开(公告)号：US20230077156A1

公开(公告)日：2023-03-09

申请号：US17717768

申请日：2022-04-11

Applicant: TriVascular, Inc.

Inventor： Syed H. Askari ,  Robert G. Whirley

IPC: A61L31/06 ,  A61K49/04 ,  A61L24/00 ,  A61L31/18 ,  A61L31/14

Abstract: Hydrogel compositions prepared from amine components and glycidyl ether components are provided which are biocompatible and suitable for use in vivo due, in part, to their excellent stability.

公开(公告)号：US10682222B2

公开(公告)日：2020-06-16

申请号：US16231219

申请日：2018-12-21

Applicant: TriVascular, Inc.

Inventor： Michael V. Chobotov ,  Robert G. Whirley ,  Joseph W. Humphrey

IPC: A61F2/07 ,  A61F2/954 ,  A61F2/966 ,  A61F2/06 ,  A61F2/848 ,  A61F2/95 ,  A61F2/89

Abstract: A hybrid modular endovascular graft wherein a main graft is sized to span at least a portion of a target vessel lesion in a large percentage of patients. Graft extensions may be secured to the main graft to extend the main graft and provide a sealing function for some applications.

公开(公告)号：US20160022410A1

公开(公告)日：2016-01-28

申请号：US14799656

申请日：2015-07-15

Applicant: TriVascular, Inc.

Inventor： Michael V. Chobotov ,  Robert G. Whirley

IPC: A61F2/07 ,  A61F2/958 ,  A61F2/89 ,  A61F2/915 ,  A61F2/82 ,  A61F2/844

CPC classification number: A61F2/07 ,  A61F2/82 ,  A61F2/844 ,  A61F2/89 ,  A61F2/915 ,  A61F2/954 ,  A61F2/958 ,  A61F2/962 ,  A61F2002/065 ,  A61F2002/072 ,  A61F2002/075 ,  A61F2002/825 ,  A61F2002/8486 ,  A61F2002/91508 ,  A61F2002/91516 ,  A61F2002/91558 ,  A61F2002/91583 ,  A61F2002/9505 ,  A61F2002/9511 ,  A61F2002/9517 ,  A61F2220/005 ,  A61F2220/0058 ,  A61F2250/0003 ,  A61F2250/0036 ,  A61M2025/0177

Abstract: This invention is a system for the treatment of body passageways; in particular, vessels with vascular disease. The system includes an endovascular graft with a low-profile delivery configuration and a deployed configuration in which it conforms to the morphology of the vessel or body passageway to be treated as well as various connector members and stents. The graft is made from an inflatable graft body section and may be bifurcated. One or more inflatable cuffs may be disposed at either end of the graft body section. At least one inflatable channel is disposed between and in fluid communication with the inflatable cuffs.

公开(公告)号：US11439497B2

公开(公告)日：2022-09-13

申请号：US16680779

申请日：2019-11-12

Applicant: TriVascular, Inc.

Inventor： Michael V. Chobotov ,  Robert G. Whirley

IPC: A61F2/07 ,  A61F2/89 ,  A61F2/82 ,  A61F2/844 ,  A61F2/915 ,  A61F2/958 ,  A61F2/954 ,  A61F2/06 ,  A61F2/848 ,  A61F2/95 ,  A61M25/01

Abstract: This invention is a system for the treatment of body passageways; in particular, vessels with vascular disease. The system includes an endovascular graft with a low-profile delivery configuration and a deployed configuration in which it conforms to the morphology of the vessel or body passageway to be treated as well as various connector members and stents. The graft is made from an inflatable graft body section and may be bifurcated. One or more inflatable cuffs may be disposed at either end of the graft body section. At least one inflatable channel is disposed between and in fluid communication with the inflatable cuffs.

公开(公告)号：US11298444B2

公开(公告)日：2022-04-12

申请号：US15068415

申请日：2016-03-11

Applicant: TRIVASCULAR, INC.

Inventor： Syed H. Askari ,  Robert G. Whirley

IPC: A61K51/00 ,  A61M36/14 ,  A61L31/06 ,  A61K49/04 ,  A61L24/00 ,  A61L31/18 ,  A61L31/14

Abstract: Hydrogel compositions prepared from amine components and glycidyl ether components are provided which are biocompatible and suitable for use in vivo due, in part, to their excellent stability.